Labeling and Linkage Agents for Immunoassays and Gene Probes

Published - Oct 2011| Analyst - Jackson Highsmith| Code - BIO038C
Market Research Report Single User License: $2,750 Member Price: FREE

Report Highlights

The market for immunoagents, probes and molecular diagnostics was $29.6 billion in 2010. This market is projected to be $33.5 billion in 2011 and will increase up to $60.3 billion by 2016 at a compound annual growth rate (CAGR) of 12.5%.

Report Scope

The Scope of this study is to outline the international supply and demand for compounds used in immunoassays and in probes, including gene probes, and related chemicals employed in diagnostic tests and in the detection of various antigens/analytes.  This study excludes separation and purification applications, which use some of these technologies. 

The industries studied in this report are:

  • In vitro diagnostics
    • Research and development laboratories
    • Point-of-Care Testing
      • Doctor’s office
      • Private medical laboratories
      • Hospitaal bedside
      • Home
    • Molecular diagnostic testing
  • In vivo diagnostics
    • Immunoassay testing
    • Monoclonal antibody therapy
  • Blood banks
  • Food Safety testing
  • Bioterrorism detection

The large number of biochemical/chemical materials covered in this report is mainly due to the diversity of the immunological tests involved. 

The immunological  biochemical products covered include:

  • Proteins
  • Antibodies and antigens
  • Cellular components
  • Nucleic acids DNA, RNA
  • Cellular receptors
  • Gene structures
  • Mutated genes involved in diseases

Analyst Credentials

Jackson Highsmith is a life sciences research consultant with more than 16 years of research experience.  Jackson has been consulting with specialty pharmaceuticals and large pharmaceutical industry players since 2007.   Prior to that, he worked at a large research consultancy where he focused on in-depth research; he also has worked at a large pharmaceutical company in a wide range of medical therapeutics in early and mid-stage drug development.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Apr-2006| Analyst - Yatin Thakore| Code - BIO038B

Report Highlights

  • In vitro and in vivo diagnostics account for nearly 87% of a total market of more than US $8.0 billion. This market will show a steady annual growth of around 6.6% for the next five years.
  • Immunoassay analysis for environmental contaminants is a promising development sector in the coming years. Though the market for probes in environmental testing is small, it is expected to grow at the rate of around 10.5% per year, due to the increasing scientific awareness, bioterrorism preparedness and funding.
  • Fluorescent compounds have the largest share of the market, followed by chemiluminescent and radioactive compounds which have about the same market share. All types of materials will have fairly healthy growth over the next five years.

RELATED REPORTS
Share This Report